RE:Positive step..Harper75 wrote: Regardless of the little to no interest in Antibe right now, I take this latest update as quite positive. Lowering the dose, adding safety buffer, potential extended patent protection...long road ahead but encouraged by the latest news.
Yes - agreed.
But I don't think the road has changed - same schedule for P2 bunionectomy (unless they announce a change).
Also, as per AGM - planning on one location for bunionectomy but that can easily become 2 locations.
Now we know why there's been little willingness to discuss fast-track application details. At AGM, all Dan would say is ... they get one chance to do it right so they need to make sure they get it right. Now we know it's related to a change in formulation and the data that comes from the change. IMO.